Ex-vivo T-cell depletion with sequential CD34+selection and OKT3 depletion for graft versus host disease prophylaxis in related haplo-identical allogeneic stem cell transplant.

被引：0
|
作者：
McGuirk, J [1 ]
Seropian, S [1 ]
Berliner, N [1 ]
Sleight, B [1 ]
Beardsley, D [1 ]
Debelak, J [1 ]
Krause, DS [1 ]
Smith, B [1 ]
Cooper, D [1 ]
机构：
[1] Yale Univ, New Haven Hosp, New Haven, CT USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4986
引用
收藏
页码：393B / 393B
页数：1
相关论文
共 50 条
  • [1] Ex-vivo T-cell depletion for graft-versus-host disease prophylaxis in related haplo-identical allogeneic stem cell transplant recipients.
    McGuirk, JP
    Abhyankar, S
    Dix, SP
    Greenfield, D
    Belt, RJ
    Picken, S
    Barnhart, C
    Gilman, A
    LEUKEMIA, 2002, 16 (03) : 412 - 412
  • [2] Ex vivo T-cell depletion for graft versus host disease prophylaxis in related haplo-identical allogeneic stem cell transplant recipients.
    McGuirk, JP
    Dix, SP
    Greenfield, D
    Belt, RJ
    Picken, S
    Meagher, R
    Jensen, K
    Barnhart, CS
    Gilman, A
    BLOOD, 2000, 96 (11) : 362B - 363B
  • [3] Distinct Biomarker Profiles in Ex-Vivo T Cell Depletion Graft Manipulation Strategies: CD34+Selection Vs CD3/19 Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation
    Cantilena, Caroline R.
    Ito, Sawa
    Tian, Xin
    Jain, Prachi
    Chinian, Fariba
    Anandi, Prathima
    Chawla, Upneet
    Draper, Debbie
    Koklanaris, Eleftheria
    Superata, Jeanine
    Stroncek, David
    Muranski, Pawel
    Barrett, John
    Battiwalla, Minoo
    BLOOD, 2016, 128 (22)
  • [4] The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation
    Ho, VT
    Soiffer, RJ
    BLOOD, 2001, 98 (12) : 3192 - 3204
  • [5] In-vivo or ex-vivo T cell depletion or both to prevent graft-versus-host disease after hematopoietic stem cell transplantation
    Busca, Alessandro
    Aversa, Franco
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (11) : 1401 - 1415
  • [6] Ex vivo T-cell depletion vs post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft-vs-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation
    Montoro, Juan
    Roldan, Elisa
    Pinana, Jose Luis
    Barba, Pere
    Chorao, Pedro
    Quintero, Abdiel
    Hernani, Rafael
    Orti, Guillermo
    Lorenzo, Jose Ignacio
    Balaguer-Rosello, Aitana
    Salamero, Olga
    Fox, Laura
    Solves, Pilar
    Gomez, Ines
    Guerreiro, Manuel
    Hernandez Boluda, Juan Carlos
    Sanz, Guillermo
    Solano, Carlos
    Sanz, Miguel Angel
    Valcarcel, David
    Sanz, Jaime
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (01) : 114 - 125
  • [7] Temporal relationship between HHV 6 and graft vs host disease in a patient after haplo-identical SCT and severe T-cell depletion
    Brands-Nijenhuis, A. V. M.
    van Loo, I. H. M.
    Schouten, H. C.
    van Gelder, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 (08) : 1151 - 1152
  • [8] Temporal relationship between HHV 6 and graft vs host disease in a patient after haplo-identical SCT and severe T-cell depletion
    A V M Brands-Nijenhuis
    I H M van Loo
    H C Schouten
    M van Gelder
    Bone Marrow Transplantation, 2011, 46 : 1151 - 1152
  • [9] ATTEMPTS AT T-CELL DEPLETION USING OKT3 AND RABBIT COMPLEMENT TO PREVENT ACUTE GRAFT VERSUS HOST-DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
    BLACKLOCK, HA
    PRENTICE, HG
    GILMORE, MJML
    PRICEJONES, E
    SCHEY, S
    TIDMAN, N
    MA, DDF
    GOLDSTEIN, G
    JANOSSY, G
    HOFFBRAND, AV
    EXPERIMENTAL HEMATOLOGY, 1983, 11 : 37 - 39
  • [10] Chronic Graft-Versus-Host Disease after Allogeneic Stem Cell Transplant with in Vivo T-Cell Depletion By Alemtuzumab: Incidence, Outcome and Pattern of Organ Involvement
    Finazzi, Maria Chiara
    Boschini, Cristina
    Ward, Janice
    Craddock, Charles
    Rambaldi, Alessandro
    Malladi, Ram
    BLOOD, 2014, 124 (21)
12345